PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study

Journal:

European Heart Journal

Published:

2026-04-16

DOI:

10.1093/eurheartj/ehag176

Affiliations:

11

Authors:

10

Go to article

Institutions	Authors	Share
Axtria, United States of America (USA)	2.000000	0.20
Mount Sinai Heart, United States of America (USA)	1.000000	0.10
University of Naples Federico II (UNINA), Italy	1.000000	0.10
Sanofi US, United States of America (USA)	1.000000	0.10
RWTH Aachen University (RWTH Aachen), Germany	1.000000	0.10
Optum, Inc., United States of America (USA)	1.000000	0.10
Hacettepe University, Turkey	1.000000	0.10
Hospital Universitario Fundación Jiménez Díaz (FJD), UAM, Spain	0.500000	0.05
Biomedical Research Networking Centers (CIBER), Spain	0.500000	0.05
Erasmus University Medical Center (Erasmus MC), Netherlands	0.500000	0.05
Sint Franciscus Gasthuis Rotterdam (SFG), Netherlands	0.500000	0.05

Interested in Cardiovascular Medicine and Haematology?